Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.-Reference-Cited by-同舟云学术

Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Published:1997-07 Issue:1 Volume:30 Page:171-179
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Mak Koon-Hou,Moliterno David J.,Granger Christopher B.,Miller Dave P.,White Harvey D.,Wilcox Robert G.,Califf Robert M.,Topol Eric J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference59 articles.

1. Morbidity and mortality in diabetics in the Framingham population;Garcia;Diabetes,1974

2. Myocardial infarction in patients with diabetes mellitus;Malmberg;Eur Heart J,1988

3. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction;Abbud;Am Heart J,1995

4. Acute myocardial infarction in 258 cases of diabetes;Partamian;N Engl J Med,1965

5. Clinical course of myocardial infarction among diabetic patients;Czyzk;Diabetes Care,1980

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes;Cardiovascular Research;2024-07-19

2. Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObservational Research Programme NSTEMI Registry of the European Society of Cardiology;European Heart Journal - Quality of Care and Clinical Outcomes;2024-01-08

3. Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes;JAMA Cardiology;2023-07-01

4. Evolocumab attenuate pericoronary adipose tissue density via reduction of lipoprotein(a) in type 2 diabetes mellitus: a serial follow-up CCTA study;Cardiovascular Diabetology;2023-05-22

5. Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction;Frontiers in Cardiovascular Medicine;2022-11-25